Trexquant Investment LP Arcturus Therapeutics Holdings Inc. Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
A detailed history of Trexquant Investment LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 74,424 shares of ARCT stock, worth $1.26 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
74,424
Previous 53,409
39.35%
Holding current value
$1.26 Million
Previous $1.3 Million
32.85%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ARCT
# of Institutions
174Shares Held
25.5MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$45 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39.3 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.7 Million0.46% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$35 Million0.02% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $451M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...